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Abstract Staphylococcus aureus strains causing human path-
ologies produce several toxins, including a pore-forming protein
family formed by the single-component K-hemolysin and the
bicomponent leukocidins and Q-hemolysins. The last comprise
two protein elements, S and F, that co-operatively form the
active toxin. K-Hemolysin is always expressed by S. aureus
strains, whereas bicomponent leukotoxins are more speci¢cally
involved in a few diseases. X-ray crystallography of the K-he-
molysin pore has shown it is a mushroom-shaped, hollow hep-
tamer, almost entirely consisting of L-structure. Monomeric F
subunits have a very similar core structure, except for the trans-
membrane stem domain which has to refold during pore forma-
tion. Large deletions in this domain abolished activity, whereas
shorter deletions sometimes improved it, possibly by removing
some of the interactions stabilizing the folded structure. Even
before stem extension is completed, the formation of an oligo-
meric pre-pore can trigger Ca2+-mediated activation of some
white cells, initiating an in£ammatory response. Within the bi-
component toxins, Q-hemolysins de¢ne three proteins (HlgA,
HlgB, HlgC) that can generate two toxins: HlgA+HlgB and
HlgC+HlgB. Like K-hemolysin they form pores in planar bi-
layers with similar conductance, but opposite selectivity (cation
instead of anion) for the presence of negative charges in the ion
pathway. Q-Hemolysin pores seem to be organized as K-hemo-
lysin, but should contain an even number of each component,
alternating in a 1:1 stoichiometry.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Pathogenicity of bacteria relies on several virulence factors
including the secretion of specialized protein toxins. Among
these, pore-forming toxins (PFT) are biological weapons that
exert a lethal action by forming oligomeric pores in the plas-
ma membrane of target cells [1,2]. They o¡er an advantage to
the bacteria by killing the incoming leukocytes, thus weaken-
ing the immune defense of the host and gaining access to
nutrients stored in those cells.
Among other pathogens, Staphylococcus aureus is quite fre-
quently isolated in human clinics. It is particularly noxious
because of the large variety of infections it can originate,
the high frequency of antibiotic-resistant strains [3,4], and
the large number of toxins it may produce. PFT are present
with a peculiar family of proteins forming L-barrel pores,
which include two subfamilies : the bicomponent leukotoxins
and the single-component K-hemolysin [5,6]. K-Hemolysin is
secreted as a monomer, but associates into a heptamer at the
surface of the target cells [7]. The active bicomponent leuko-
toxins, instead, are formed by the association of two distinct
and separately secreted proteins, indicated as class S and F [8].
To date, at least six S proteins and ¢ve F proteins are known
(Table 1). They include Q-hemolysins (as ubiquitous as K-he-
molysin in pathogenic strains of S. aureus), Panton^Valentine
(PVL) and LukE-LukD leukocidins, sometimes associated
with other staphylococcal toxins in speci¢c diseases (impetigo
and antibiotic-associated diarrhea, respectively).
A precise characterization of the molecular events under-
lying the biological activity of these PFT is important not
only for understanding bacterial virulence, but also to inves-
tigate the basic mechanisms of protein^membrane interac-
tions.
2. Genetics and puri¢cation of staphylococcal L-barrel PFT
Four leukotoxin operons have been characterized in S. au-
reus : the Q-hemolysin (HlgA and HlgC/B), the PVL (LukS-PV/
F-PV) [9], LukE/D [10] and LukM/F-PV-like [11]. The genes
are chromosomal and are cotranscribed, the one encoding the
S protein being upstream of that encoding the F protein. They
are not collected in pathogenicity islands, except for lukE/D
that is near to the egc operon encoding several enterotoxins
[10,12], but may be located in the vicinity of operons encoding
metabolic functions (e.g. the Q-hemolysin and the biotin oper-
ons) [9]. The regulation of the expression level is usually de-
pendent on the regulation complex agr/sar [13].
Class S and class F proteins share around 30% identity, but
within each class, the identity scores are higher (between 55
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and 81%) [14]. A phylogenetic tree [15] suggests the existence
of a common ancestor, from which the bicomponent toxins
evolved through duplication followed by complementary mu-
tations, which blocked self-aggregation and allowed heterolo-
gous aggregation [16]. Other single-component toxins of the
same family have been found in di¡erent bacteria, e.g. Bacillus
subtilis and Clostridium perfringens [5,6].
The secreted proteins can be concentrated by precipitation
with ammonium sulfate and puri¢ed by a combination of ion
exchange and hydrophobic interaction chromatography
[14,17]. They are thermolabile and cysteineless, they have
around 300 amino acids, a net positive charge (pI 8.5), solu-
bility up to 1^5 mg/ml, and a predominance of L-structure.
3. Epidemiological and clinical links
All the strains isolated in human clinics produce in vitro
more than 1 Wg/ml K- and Q-hemolysin [7,17,18]. Around 30%
of strains also produce noticeable quantities of LukE/D [9],
despite this operon is more frequent. Only 2% of strains pos-
sess and express the genes for PVL, which, however, charac-
terize more than 90% of the strains isolated from furuncle
[19]. PVL-producing strains may also cause community pneu-
mopathies [20,21] and urogenital infections [22]. Interestingly,
about 90% of S. aureus strains isolated from antibiotic-asso-
ciated diarrheas produce LukE/D in association with entero-
toxin A [23] and 80% of strains isolated from impetigo con-
tagiosa produce LukE/D and one epidermolysin (A or B) [24].
The LukM/F-PV-like operon has, in contrast, never been iso-
lated in human clinics.
4. Target cells and cellular response
Injection of leukotoxins into the rabbit vitreous humor pro-
vokes major in£ammatory reactions [25], thus providing an
important animal model. The privileged target cells of bicom-
ponent leukotoxins are the monocytes, the macrophages and
the polymorphonuclear (PMN) cells [8,9]. HlgA/B and HlgC/
B can also lyse erythrocytes [9,26]. K-Hemolysin has a wider
spectrum of action adding T lymphocytes [27], platelets [28],
epithelial cells [29] and ¢broblasts [30].
The response of human neutrophils is multiple and leads to
the secretion of granular mediators of cytotoxicity, chemotac-
tism and vasodilatation [31^33], and to the release of inter-
leukins, enzymes and oxidizing elements [34]. K-Hemolysin
also induces the degranulation of platelets with a reduction
of clotting time [28]. Some S. aureus strains produce up to
seven di¡erent bicomponent proteins, carried by the loci hlg,
lukS/F-PV and lukE/D. Given the close similarity between
these components, the possibility arises that new toxins are
formed combining the products of di¡erent operons. In prin-
ciple, any class S component (HlgA or HlgC or LukS or
LukE) could give an active toxin with any class F component
(HlgB or LukF or LukD). Indeed, many non-classical couples
have been found to be active on cellular systems, e.g. HlgA-
LukF and LukS-HlgB [9,26]. Interestingly, the cell speci¢city
of the new couples is di¡erent from that of the classical ones,
suggesting that this combinatorial mechanism may give an
adaptive advantage to the microorganism.
5. Three-dimensional structure
The structure of the pore formed by the K-hemolysin hep-
tamer was obtained by co-crystallization with a detergent [35].
The overall shape resembles a mushroom, therefore, the three
structural domains that compose it were called: cap, the ex-
ternal part, rim, the domain anchoring to the membrane, and
stem, the L-barrel that perforates the membrane (Fig. 1). The
cap has a diameter of 100 AM and is composed of a L-sandwich
of 2U6 antiparallel L-strands for each monomer, representing
55% of the residues. Together with the rim it forms the core of
the protein. The N-terminal extremity detaches from each
monomer and interacts with the next two protomers around
the entrance of the pore, forming a latch. The monomer/
monomer interfaces involve a series of contacts between res-
idues of adjacent units, e.g. His35-Ser99, His48-Asp24, Lys37-
Asp100. The 37 consecutive residues of the stem (from Glu111
to Lys147) are organized in a L-hairpin, connected to the cap
by the triangle region. Seven hairpins associate to form a
transmembrane L-barrel of 52 AM length and 26 AM average
diameter. Charged residues exposed inside the lumen of the
stem are coupled to form two rings of alternating charges,
Table 1
Properties of S. aureus proteins belonging to the K-hemolysin family of L-barrel PFT
Toxin/proteina Acronym PDBb GenBank Number of
amino acids
Mr Leukocytesc Red blood
cellsc
Large
unilamellar
vesiclesc
K-Hemolysin K-HL 7AHL M90536 293 33 249 ++ ++ ++
Leukocidin S-PV S LukS-PV X72700 286 32 529 ++ 3 3
Leukocidin F-PV F LukF-PV 1PVL 301 34 384
Leukocidin S-Rd S LukS-R X64389 286 32 536 ++ 3 3
Leukocidin F-Rd F LukF-R 299 34 138
Leukocidin E S LukE Y13225 286 32 304 + + 3
Leukocidin D F LukD 301 34 206
Leukocidin M S LukM D42144 280 32 010 + + 3
Leukocidin F-PV like F LukFP-PV D83951 296 33 687
Q-Hemolysin A S HlgA L01055 281 31 994 ++e ++ ++
Q-Hemolysin B F HlgB 1LKF 300 34 121
Q-Hemolysin C S HlgC 286 32 554 ++ + +
aNext to bicomponent proteins it is indicated whether they are of the S or F type.
bReferences for the PDB ¢les are as follows: 7AHL [35]; 1PVL [37]; 1LKF [36]
cSensitivity of cells or model membranes: ++, high; +, moderate; 3, nil.
dLukS-R and LukF-R (X64389) correspond to HlgC and HlgB (L01055) [71].
eThe upper row refers to the couple HlgA-HlgB the lower row to the couple HlgC-HlgB.
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Glu111-Lys147 at one entrance and Asp127-Lys131 at the
other.
The three-dimensional structures of the monomeric, soluble
form of HlgB and LukF-PV were also determined [36,37].
Their overall arrangement is very similar to that of K-hemo-
lysin (Fig. 1) though the rim domains are rotated by 11‡ and
15‡ (for HlgB and LukF-PV respectively), and their N-termi-
nal extremity sticks to the L-sandwich body forming an addi-
tional strand. Most importantly, the stem and the triangle
region are folded against the core of the protein in three
antiparallel L-strands covering a hydrophobic interface of
2750 AM 2. These major di¡erences give some hints on the struc-
tural modi¢cations occurring during pore formation, e.g. the
change of folding of the stem.
6. Mode of action
The interaction of these S. aureus PFT with biological
membranes has a common, multi-step pathway which in-
cludes: binding, oligomerization, insertion and assembly of
a L-barrel which forms the functional pore [38].
6.1. Binding
Within the bicomponent toxins, the S protein is the one that
attaches ¢rst to the target cell, thereby allowing the secondary
binding of the F protein and the expression of biological
activity [39]. The binding of LukS-PV and HlgC is diminished
by treating cells with phorbol myristyl acetate (PMA), a stim-
ulator of the regulation pathway of protein kinase C, and is
maximal with staurosporine, a suppressor of the same system
[40]. These observations may suggest the participation of a
still unidenti¢ed receptor to the binding. LukS-PV and
HlgC compete for the same binding sites, but HlgA and
LukE do not. HlgA has, besides a speci¢c binding, also an
unspeci¢c binding [41]. Q-Hemolysins can permeabilize even
synthetic membranes containing only phosphatidylcholine
(PC) and cholesterol [26,41]. Other leukotoxins, e.g. the
PVL, aggregate on the same membranes, but do not form a
functional pore. Therefore, the composition of the host mem-
brane can modulate not only the binding, but also the tran-
sition to the functional pore. K-Hemolysin is also active on
PC/cholesterol vesicles [42], yet, at variance with the leukotox-
ins, its action on T lymphocytes is stimulated rather than de-
pressed by PMA [39].
6.2. Oligomerization of the monomers
Evidence from electron microscopy (EM), molecular and
structural biology, indicated the formation of heptamers by
K-hemolysin [35,43], though the presence of hexamers was
also noted [44]. During oligomerization, monomer^monomer
interactions are established, which involve His35. Using acryl-
odan, a £uorescent probe sensitive to environmental polarity,
it was shown that the stem domain does not unfold until an
oligomeric pre-pore is formed [45]. Residue Thr28 of LukS-
PV and HlgC, or the corresponding Thr30 of HlgA, is also
sensitive to substitutions and a¡ects the secondary binding of
the F component [41]. This position corresponds to His35 of
K-hemolysin, and most probably participates in interface con-
tacts between bicomponent monomers [37].
In the case of Q-hemolysins the stoichiometry of the pore is
still debated. Early analysis of EM pictures of lesions in red
blood cells (RBC) and PMN led Sugawara et al. to suggest
the presence of a hexamer containing an equimolar ratio of
each component [46,47]. A study of pores formed in lipid
vesicles came to the same conclusion [26] based on two lines
of evidence: on average, the lesions contained equal amounts
of each component, implying the presence of an even number
of protomers; the apparent MW was around 200 kDa, com-
patible with the assembly of six monomers. It could not be
excluded, however, that these toxins may form an equally
populated mixture of two types of pores containing 4:3 and
3:4 combinations of the two components. Indeed a new, more
thorough examination of EM pictures led Sugawara’s group
to the conclusion that cell lesions are equimolar mixtures of
two iso-probable heptameric forms, with 4:3 and 3:4 ratios of
the two components [48]. A careful inspection of the pub-
Fig. 1. Crystal structure of the K-hemolysin (K-HL) heptameric pore and the HlgB monomer based on the PDB ¢les 7AHL [35] and 1LKF
[36]. A cartoon representation of the three-dimensional structure of one K-HL protomer is highlighted in color and either superimposed on the
molecular surface representation of the whole pore (left), or extracted and represented alone (center). The same representation is given of the
monomeric HlgB molecule (right). The surface and the cartoon representations were generated by the program PyMOL v.0.86 [72].
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lished pictures, however, highlights a strong asymmetry of the
analyzed images, the part of the structure containing four
protomers being smaller than the part with the other three.
This asymmetry, also recognized by the authors [48], makes it
di⁄cult to reconcile the reported EM images with a perfectly
axially symmetrical structure such as that observed with K-
hemolysin (see Fig. 1) and suggests they may rather represent
an intermediate on the pathway to form a completely devel-
oped pore. In fact, heptamers were declared to be only the
most abundant form in the EM images [48]. Another group,
analyzing the conductance levels of pores in which a single
cysteine was introduced in one component and modi¢ed with
a thiol-speci¢c negatively charged reagent, came to the con-
clusion that the reconstituted functional pores contain four
copies of each component, being in fact octamers [16]. A
way to reconcile these di¡erent ¢ndings is to assume that
hexamers, heptamers and octamers may actually co-exist on
the membrane. However, it would remain to be established if
all these forms are functional and which one is the most
important in vivo.
6.3. Insertion of the hairpins
The insertion of the stem hairpins of K-hemolysin in the
membrane of rabbit RBC or liposomes was investigated by
the transfer of acrylodan-labeled newly introduced single cys-
teines [49]. In the ¢nal state, the lateral chains of stem residues
are oriented alternately one towards the membrane and the
other towards the lumen, and create an amphiphilic L-barrel.
The process of insertion is rather slow, and the ¢rst evidence
of a leukotoxin, and possibly also K-hemolysin activity, is a
quick entry of Ca2þ through toxin-activated endogenous cell
channels [50^52]. This activity, detected by Ca2þ indicators, is
selectively inhibited by econazole (a blocker of Ca2þ channels
[50]), is independent of the presence of functional toxin pores
and can follow an even incomplete stem refolding. Ethidium
(Etþ) entry, instead, indicates that the formation of toxin
pores occurs later and is reduced by high concentrations of
Ca2þ. In LukF-PV (associated with LukS-PV) the substitution
Gly130Cys, or the deletion vGly127^Ser129, considerably de-
creases Etþ entry, but leaves enough Ca2þ activation to in-
duce the secretion of interleukin-8 [53,54]. Interestingly, this
modi¢ed PVL is incapable of starting dermonecrosis in the
rabbit eye, demonstrating that the ability to form pores is
important for pathogenesis. The reason is probably that cell
lysis, caused by pore formation, liberates larger amounts of
in£ammatory molecules, releases nutrients useful for the bac-
teria and creates cell ghosts that misdirect the host immune
system.
To study stem refolding and insertion, a set of mutant
LukF-PV proteins were produced with variable deletions in
this region [54]. Larger deletions completely abolished cellular
activity, probably leaving a stem too short to span the mem-
brane. Smaller deletions, instead, retained Ca2þ-activating and
Etþ-entry properties. Some of these, e.g. vIle124^Asn126 and
vSer125^Gly127, were actually more potent than the wild-
type, demonstrating that stem refolding is a crucial event,
Fig. 2. Electrical properties of K-hemolysin and Q-hemolysin pores. Top: Schematic of the ¢xed charges which are present in the lumen and at
the two entrances of the stem region of the pore. Three natural toxins and the A108B mutant, in which the positive charge K108 of HlgA has
been replaced with the uncharged threonine, are reported. Middle: Single-channel conductances, reported in cumulative probability histograms,
for the four toxins analyzed. Bottom: Selectivity of the channels, reported as the cation/anion permeability ratio (P+/P3), calculated according
to the Goldman^Hodgkin^Katz equation. Data are taken and adapted from [63]. Abbreviations: K-HL, K-hemolysin; A, HlgA; B, HlgB; C,
HlgC.
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which may be facilitated by small deletions that remove some
of the intra-chain interactions stabilizing the folding of the
soluble form.
6.4. The ¢nal pore
According to crystal data [35], the diameter of the hepta-
meric K-hemolysin pore is not constant and varies along its
lumen. It is around 30 AM at the entrance, a maximum of 38 AM
in the vestibule (inside the cap), a minimum of 14 AM at a
constriction formed by Lys145 at the beginning of the trans-
membrane stem and between 20 and 22 AM along the rest (Fig.
2). Similar entrance diameters were also deduced from low-
resolution EM images [55,56], or atomic force microscopy
[43,44], or from the di¡erential permeability of sugar mole-
cules of di¡erent sizes through pores reconstituted in arti¢cial
membranes [57]. In the EM, leukotoxin lesions appear re-
markably similar to K-hemolysin, with an entrance diameter
between 20 and 30 AM [46,47].
This is a big diameter when compared to a water molecule
(2 AM ), yet remains a very small cavity, where the solute move-
ment is di¡erent from the bulk solution and can be dominated
by local electrostatic ¢elds generated by the charged amino
acids [58,59]. When the ion conductance properties of the
pores are directly compared in model membranes, some strik-
ing di¡erences appear. The K-hemolysin pore is anion-selec-
tive and has a conductance of 90 pS in 0.1 M NaCl and 775
pS in 1 M KCl [60,61] (Fig. 2). On the other hand, the selec-
tivity of the leukotoxin pores is cationic, as indicated by the
transport of Etþ, Kþ and Naþ in target cells [53,62], and by
the reversal voltages in synthetic membranes [63]. The con-
ductance of the HlgA-HlgB pore in 0.1 M NaCl is 115 pS,
that of HlgC-HlgB is 190 pS (and 2500 pS in 1 M KCl)
[63,64]. These values are markedly higher than those of
K-hemolysin, and could suggest a larger pore diameter, in
contrast with structural indications.
A direct method to assess the hydrodynamic radius of the
pore formed by these toxins in RBC is to determine the rate
of colloid osmotic hemolysis in the presence of neutral solutes
of di¡erent sizes. We did this using a series of oligosaccharides
or polyethylene glycols (PEGs) of increasing size (see Fig. 3).
The relative permeability of each osmolyte was derived and
found to be inversely related to its size. The data were ar-
ranged in a Renkin plot (see [65]), providing an estimate of
pore radius. This radius was independent of the toxin concen-
tration (Fig. 3), though this dictates the absolute rate of he-
molysis. However, di¡erent values were obtained using the
PEG or the oligosaccharide series (for K-hemolysin 14 AM
and 9 AM , respectively, Fig. 3). This could be due to the fact
that PEGs are polydisperse, or that they can assume a non-
spherical shape squeezing inside pores narrower than their
theoretical diameter. Accordingly, estimates with oligosaccha-
rides should be considered more reliable. The values observed
for other bicomponent couples were as follows: 14.2 AM and
9.8 AM for HlgA-HlgB; 14.7 AM and 9.3 AM for HlgC-HlgB; 14.3
AM and 9.2 AM for LukE-LukD (where the ¢rst number always
refers to the PEGs and the second to the oligosaccharides). It
therefore appears that the pore sizes of the di¡erent toxins are
in fact quite similar. The small di¡erences observed (bicom-
ponent pores up to 10% bigger than K-hemolysin pore) could
be due either to a larger stoichiometry (octamers instead of
heptamers), or to the absence of the constriction at the en-
trance of the stem, since Lys147 of K-hemolysin is replaced by
less bulky residues in the bicomponent toxins (either Asn or
Ser).
Ion conductance di¡erences should therefore be due to the
in£uence of charges that are present in the pore lumen (Fig.
2). Inspection of sequence alignments in the stem region in-
dicated interesting di¡erences. The lumen of the stem of the
K-hemolysin pore is neutral because of charge compensation
between the residues, i.e. Glu111-Lys147 at its entrance and
Asp127-Lys131 at its exit. A similar compensation occurs in
Fig. 3. Osmotic protection experiments. Top: Schematic of the pas-
sage of electrically neutral molecules through the K-hemolysin pore.
Sugars (right) are considered spherical rigid particles, polymeric
PEGs (left) are instead supposed to be more £exible, and therefore
prone to adopt elongated shapes, allowing them to pass more easily
through the channel constrictions [65]. Middle: Kinetics of human
RBC hemolysis caused by K-hemolysin (0.22 WM for PEG and 0.11
WM for sugar experiments) in the presence of 30 mM osmotic pro-
tectants in the external bu¡er. The protectants used are reported
next to each trace and were: PEG200 (0.40), PEG300 (0.48),
PEG600 (0.69), PEG900 (0.85), PEG1000 (0.89) in the left panel;
arabinose (0.38), ra⁄nose (0.66), stachyose (0.75), maltohexaose
(M6, 0.90) in the right panel (in brackets is the hydrated radius, in
nm [65]). The trace labeled ‘buf’ is the control without protectant.
Bottom: Renkin plot reporting the relative di¡usion rates of the os-
motic protectants vs. their hydrated radii [65]. Lines through the
points are best ¢ts giving a pore radius of 1.40W 0.05 nm for PEGs
and 0.90W 0.05 nm for sugars. Reference molecules were PEG200
(left) and arabinose (right). The larger apparent pore radius ob-
tained in PEG experiments is probably related to the £exibility of
PEG molecules, which can more easily change their shape when
forced to £ow through the pore. For both protectants, radius esti-
mation was independent of toxin concentration (di¡erent toxin con-
centrations are indicated with di¡erent symbols), suggesting a stable
structure of the pore, which does not change in size with toxin
dose.
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the HlgA-HlgB pore between entrance charges (Glu107-
Lys145 in HlgB and Asp104-Lys140 in HlgA) as well as in-
ternal charges, i.e. Asp121 of HlgB and Lys108 of HlgA.
However, in the HlgC-HlgB pore, residue Asp121 of HlgB
is not compensated because of the lack of a positive residue
such as Lys108 of HlgA. This uncompensated negative charge
is conceivably the reason for the larger conductance and high-
er cation selectivity of the HlgC-HlgB pore. Consistently, we
saw that the pore formed by HlgALys108Thr-HlgB (where the
positive charge of Lys108 of HlgA was removed) was as cat-
ion-selective and almost as conductive as the HlgC-HlgB pore
(Fig. 2). Meanwhile, the pore formed by HlgALys108Thr-
HlgBAsp121Asn, where both charges were removed, retrieved a
neutral stem lumen and the same conductive properties of
wild-type HlgA-HlgB [63]. We concluded that conductance
and selectivity of the Q-hemolysin pores depend substantially
on the presence and location of charged residues in the chan-
nel, suggesting that these pores work as electrostatic ¢lters.
7. Conclusions
Though belonging to a single structural family, K-hemolysin
and the bicomponent leukotoxins seem to have been selected,
or at least maintained, by S. aureus to have a wider range of
virulence factors in terms of both cellular speci¢city and pore
properties. Di¡erent animal experiments have shown that
strains de¢cient for one or the other of these genes do not
achieve the same infectious levels as the wild counterparts
[14,66]. The bicomponent leukotoxins introduce an additional,
important element of variability, due to the possibility of as-
sembling di¡erent toxins by combination of di¡erent gene
products.
Besides important for understanding the molecular basis of
staphylococcal diseases, these studies have led to relevant
advances in understanding protein integration in lipid mem-
branes and in proposing pertinent models. They also sug-
gested some conceptually new applications: Bayley and co-
workers were able to use suitably modi¢ed K-hemolysin chan-
nels as stochastic sensors of pollutants, organic molecules or
other substrates [67^69], and for the cryopreservation of stem
cells [70].
Acknowledgements: This work was ¢nancially supported by structural
funds of the Consiglio Nazionale delle Ricerche (CNR) and the Isti-
tuto Trentino di Cultura (ITC), by research funds of the Provincia
Autonoma di Trento (PAT) Fondo Progetti (Project StaWars), of the
Institut de Bacte¤riologie de la Faculte¤ de Me¤decine de Strasbourg and
by Grant EA-1318 from the Direction de la Recherche et des Etudes
Doctorales (DRED). During part of the work S.W. was supported by
a FEBS short-term fellowship.
References
[1] van der Goot, F.G. (2001) Pore-forming Toxins, Springer Verlag,
Berlin.
[2] Menestrina, G., Dalla Serra, M. and Lazarovici, P. (2003) Pore-
forming Peptides and Protein Toxins, Taylor and Francis, Lon-
don.
[3] Astagneau, P., Fleury, L., Leroy, S., Lucet, JC., Golliot, F.,
Re¤gnier, B. and Brucker, G. (1999) J. Hosp. Infect. 42, 303^312.
[4] Kloos, W.E. and Bannerman, T.L. (1999) in: Manual of Clinical
Microbiology (Murray, P.R., Baron, E.J., Pfaller, M.A., Ten-
over, F.C. and Yolken, R.H., Eds.), pp. 264^282, ASM Press,
Washington, DC.
[5] Pre¤vost, G., Mourey, L., Colin, D.A. and Menestrina, G. (2001)
in: Pore-forming Toxins, Vol. 257 (van der Goot, F.G., Ed.), pp.
53^83, Springer Verlag, Berlin.
[6] Menestrina, G., Dalla Serra, M. and Pre¤vost, G. (2001) Toxicon
39, 1661^1672.
[7] Bhakdi, S., Bayley, H., Valeva, A., Walev, I., Walker, B., Weller,
U., Kehoe, M. and Palmer, M. (1996) Arch. Microbiol. 165, 73^
79.
[8] Woodin, A.M. (1972) in: The Staphylococci (Cohen J.O., Ed.),
pp. 281^289, Wiley-Interscience, New York.
[9] Pre¤vost, G., Cribier, B., Couppie¤, P., Petiau, P., Supersac, G.,
Finck-BarbancYon, V., Monteil, H. and Pie¤mont, Y. (1995) Infect.
Immun. 63, 4121^4129.
[10] Gravet, A., Colin, D.A., Keller, D., Girardot, R., Monteil, H.
and Pre¤vost, G. (1998) FEBS Lett. 436, 202^208.
[11] Kaneko, J., Muramoto, K. and Kamio, Y. (1997) Biosci. Bio-
technol. Biochem. 61, 541^544.
[12] Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H.,
Kobayashi, I., Cui, L., Oguchi, A., Aoki, K., Nagai, Y., Lian,
J., Ito, T., Kanamori, M., Matsumaru, H., Maruyama, A., Mu-
rakami, H., Hosoyama, A., Mizutani-Ui, Y., Takahashi, N.K.,
Sawano, T., Inoue, R., Kaito, C., Sekimizu, K., Hirakawa, H.,
Kuhara, S., Goto, S., Yabuzaki, J., Kanehisa, M., Yamashita,
A., Oshima, K., Furuya, K., Yoshino, C., Shiba, T., Hattori, M.,
Ogasawara, N., Hayashi, H. and Hiramatsu, K. (2001) Lancet
357, 1225^1240.
[13] Bronner, S., Stoessel, P., Gravet, A., Monteil, H. and Pre¤vost, G.
(2000) Appl. Environ. Microbiol. 66, 3931^3938.
[14] Pre¤vost, G. (1999) in: The Comprehensive Sourcebook of Bacte-
rial Protein toxins (Alouf, J.E. and Freer, J.H., Eds.), pp. 402^
418, Academic Press, London.
[15] Pre¤vost, G., Menestrina, G., Colin, D.A., Werner, S., Bronner,
S., Dalla Serra, M., Baba Moussa, L., Coraiola, M., Gravet, A.
and Monteil, H. (2003) in: Pore-forming Peptides and Protein
Toxins, Vol. 5 (Menestrina, G., Dalla Serra, M. and Lazarovici,
P., Eds.), pp. 3^26, Taylor and Francis, London.
[16] Miles, G., Movileanu, L. and Bayley, H. (2002) Protein Sci. 11,
894^902.
[17] Pre¤vost, G., Bouakkam, T., Pie¤mont, Y. and Monteil, H. (1995)
FEBS Lett. 376, 135^140.
[18] Pre¤vost, G., Couppie¤, P., Pre¤vost, P., Gayet, S., Petiau, P., Cri-
bier, B., Monteil, H. and Pie¤mont, Y. (1995) J. Med. Microbiol.
42, 237^245.
[19] Couppie¤, P., Cribier, B., Pre¤vost, G., Grosshans, E. and Pie¤mont,
Y. (1994) Arch. Dermatol. 130, 1208^1209.
[20] Couppie¤, P., Hommel, D., Pre¤vost, G., Godart, M.C., Moreau,
B., Sainte-Marie, D., Peneau, C., Hulin, A., Monteil, H.
and Pradinaud, R. (1997) Ann. Dermatol. Venereol. 124, 684^
686.
[21] Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.C., Lina, G., Bes,
M., Vandenesch, F., Pie¤mont, Y., Brousse, N., Floret, D. and
Etienne, J. (2002) Lancet 359, 753^759.
[22] Baba-Moussa, L., Sanni, A., Dagnra, A.Y., Anagonou, S.,
Prince-David, M., Edoh, V., Befort, J.J., Pre¤vost, G. and Mon-
teil, H. (1999) Me¤d. Mal. Infect. 29, 689^696.
[23] Gravet, A., Rondeau, M., Harf-Monteil, C., Grunenberger, F.,
Monteil, H., Scheftel, J.M. and Pre¤vost, G. (1999) J. Clin. Micro-
biol. 37, 4012^4019.
[24] Gravet, A., Couppie¤, P., Meunier, O., Clyti, E., Moreau, B.,
Pradinaud, R., Monteil, H. and Pre¤vost, G. (2001) J. Clin. Mi-
crobiol. 39, 4349^4356.
[25] Siqueira, J.A., Speeg-Schatz, C., Freitas, F.I., Sahel, J., Monteil,
H. and Pre¤vost, G. (1997) J. Med. Microbiol. 46, 486^494.
[26] Ferreras, M., Ho«per, F., Dalla Serra, M., Colin, D.A., Pre¤vost,
G. and Menestrina, G. (1998) Biochim. Biophys. Acta 1414, 108^
126.
[27] Jonas, D., Walev, I., Berger, T., Liebetrau, M., Palmer, M. and
Bhakdi, S. (1994) Infect. Immun. 62, 1304^1312.
[28] Bhakdi, S., Muhly, M., Mannhardt, U., Hugo, F., Klappatek,
K., Mueller-Eckhardt, C. and Roka, L. (1988) J. Exp. Med. 168,
527^542.
[29] Walev, I., Martin, E., Jonas, D., Mohamadzadeh, M., Mu«ller-
Klieser, W., Kunz, L. and Bhakdi, S. (1993) Infect. Immun. 61,
4972^4979.
[30] Walev, I., Palmer, M., Martin, M., Jonas, D., Weller, U., Hoehn-
FEBS 27549 4-9-03 Cyaan Magenta Geel Zwart
G. Menestrina et al./FEBS Letters 552 (2003) 54^60 59
Bentz, H., Husmann, M. and Bhakdi, S. (1994) Microb. Patho-
gen. 17, 187^201.
[31] Ko«nig, B., Ko«ller, M., Pre¤vost, G., Pie¤mont, Y., Alouf, J.E.,
Schreiner, A. and Ko«nig, W. (1994) Infect. Immun. 62, 4831^
4837.
[32] Hensler, T., Ko«nig, B., Pre¤vost, G., Pie¤mont, Y., Ko«ller, M. and
Ko«nig, W. (1994) Infect. Immun. 62, 2529^2535.
[33] Konig, B., Pre¤vost, G., Piemont, Y. and Konig, W. (1995)
J. Infect. Dis. 171, 607^613.
[34] Ko«nig, B., Pre¤vost, G. and Ko«nig, W. (1997) J. Med. Microbiol.
46, 479^485.
[35] Song, L., Hobaugh, M.R., Shustak, C., Cheley, S., Bayley, H.
and Gouaux, J.E. (1996) Science 274, 1859^1866.
[36] Olson, R., Nariya, H., Yokota, K., Kamio, Y. and Gouaux, J.E.
(1999) Nat. Struct. Biol. 6, 134^140.
[37] Pe¤delacq, J.-D., Maveyraud, L., Pre¤vost, G., Baba-Moussa, L.,
Gonzalez, A., Courcelle, E., Shepard, W., Monteil, H., Samama,
J.-P. and Mourey, L. (1999) Structure 7, 277^287.
[38] Lesieur, C., Ve¤csey-Semje¤n, B., Abrami, L., Fivaz, M. and van
der Goot, F.G. (1997) Mol. Membr. Biol. 14, 45^64.
[39] Colin, D.A., Mazurier, I., Sire, S. and Finck-BarbancYon, V.
(1994) Infect. Immun. 62, 3184^3188.
[40] Gauduchon, V., Werner, S., Pre¤vost, G., Monteil, H. and Colin,
D.A. (2001) Infect. Immun. 69, 2390^2395.
[41] Meunier, O., Ferreras, M., Supersac, G., Ho«per, F., Baba-Mous-
sa, L., Monteil, H., Colin, D.A., Menestrina, G. and Pre¤vost, G.
(1997) Biochim. Biophys. Acta 1326, 275^286.
[42] Forti, S. and Menestrina, G. (1989) Eur. J. Biochem. 181, 767^
773.
[43] Malghani, M.S., Fang, Y., Cheley, S., Bayley, H. and Yang, J.
(1999) Microsc. Res. Tech. 44, 353^356.
[44] Czajkowsky, D.M., Sheng, S.T. and Shao, Z.F. (1998) J. Mol.
Biol. 276, 325^330.
[45] Valeva, A., Palmer, M. and Bhakdi, S. (1997) Biochemistry 36,
13298^13304.
[46] Sugawara, N., Tomita, T. and Kamio, Y. (1997) FEBS Lett. 410,
333^337.
[47] Sugawara, N., Tomita, T., Sato, T. and Kamio, Y. (1999) Biosci.
Biotechnol. Biochem. 63, 884^891.
[48] Sugawara-Tomita, N., Tomita, T. and Kamio, Y. (2002) J. Bac-
teriol. 184, 4747^4756.
[49] Valeva, A., Weisser, A., Walker, B., Kehoe, M., Bayley, H.,
Bhakdi, S. and Palmer, M. (1996) EMBO J. 15, 1857^1864.
[50] Staali, L., Monteil, H. and Colin, D.A. (1998) J. Membr. Biol.
162, 209^216.
[51] Fink, D., Contreras, M.L., Lelkes, P.I. and Lazarovici, P. (1989)
Cell. Signal. 1, 387^393.
[52] Meunier, O., Falkenrodt, A., Monteil, H. and Colin, D.A. (1995)
Cytometry 21, 241^247.
[53] Baba-Moussa, L., Werner, S., Colin, D.A., Mourey, L., Pe¤de-
lacq, J.-D., Samama, J.P., Sanni, A., Monteil, H. and Pre¤vost,
G. (1999) FEBS Lett. 461, 280^286.
[54] Werner, S., Colin, D.A., Coraiola, M., Menestrina, G., Monteil,
H. and Pre¤vost, G. (2002) Infect. Immun. 70, 1310^1318.
[55] Fu«ssle, R., Bhakdi, S., Sziegoleit, A., Tranum-Jensen, J., Kranz,
T. and Wellensiek, H.J. (1981) J. Cell Biol. 91, 83^94.
[56] Ward, R.J. and Leonard, K. (1992) J. Struct. Biol. 109, 129^
141.
[57] Krasilnikov, O.V., Merzlyak, P.G., Yuldasheva, L.N., Azimova,
R.K. and Nogueira, R.A. (1997) Med. Microbiol. Immunol. 186,
53^61.
[58] Menestrina, G. and Ve¤csey-Semje¤n, B. (1999) in: The Compre-
hensive Sourcebook of Bacterial Protein Toxins (Alouf, J.E. and
Freer, J.H., Eds.), pp. 287^309, Academic Press, London.
[59] Howorka, S. and Bayley, H. (2002) Biophys. J. 83, 3202^3210.
[60] Menestrina, G. (1986) J. Membr. Biol. 90, 177^190.
[61] Krasilnikov, O.V., Ternovskii, V.I., Sabirov, R.Z., Zaripova,
R.K. and Tashmukhamedov, B.A. (1986) Biophysics 31, 658^
663.
[62] Finck-BarbancYon, V., Duportail, G., Meunier, O. and Colin,
D.A. (1993) Biochim. Biophys. Acta 1182, 275^282.
[63] Comai, M., Dalla Serra, M., Coraiola, M., Werner, S., Colin,
D.A., Pre¤vost, G. and Menestrina, G. (2002) Mol. Microbiol. 44,
1251^1268.
[64] Miles, G., Cheley, S., Braha, O. and Bayley, H. (2001) Biochem-
istry 40, 8514^8522.
[65] Tejuca, M., Dalla Serra, M., Alvarez, C., Potrich, C. and Me-
nestrina, G. (2001) J. Membr. Biol. 183, 125^135.
[66] Supersac, G., Pie¤mont, Y., Kubina, M., Pre¤vost, G. and Foster,
T.J. (1998) Microb. Pathogen. 24, 241^251.
[67] Braha, O., Walker, B., Cheley, S., Kasianowicz, J.J., Song, L.,
Gouaux, J.E. and Bayley, H. (1997) Chem. Biol. 4, 497^505.
[68] Gu, L.Q., Braha, O., Conlan, S., Cheley, S. and Bayley, H.
(1999) Nature 398, 686^690.
[69] Gu, L.Q., Dalla Serra, M., Vincent, J.B., Vigh, G., Cheley, S.,
Braha, O. and Bayley, H. (2000) Proc. Natl. Acad. Sci. USA 97,
3959^3964.
[70] Eroglu, A., Russo, M.J., Bieganski, R., Fowler, A., Cheley, S.,
Bayley, H. and Toner, M. (2000) Nat. Biotechnol. 18, 163^
167.
[71] Supersac, G., Pre¤vost, G. and Pie¤mont, Y. (1993) Infect. Immun.
61, 580^587.
[72] DeLano, W.L. (2003) The PyMOL Molecular Graphics System,
DeLano Scienti¢c LLC, San Carlos, CA.
FEBS 27549 4-9-03 Cyaan Magenta Geel Zwart
G. Menestrina et al./FEBS Letters 552 (2003) 54^6060
